ACSL6 Antikörper (Middle Region)
Kurzübersicht für ACSL6 Antikörper (Middle Region) (ABIN2775415)
Target
Alle ACSL6 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Sequenz
- GPGAIRYIIN TADISTVIVD KPQKAVLLLE HVERKETPGL KLIILMDPFE
-
Homologie
- Cow: 100%, Dog: 100%, Guinea Pig: 93%, Horse: 100%, Human: 100%, Mouse: 100%, Pig: 100%, Rabbit: 93%, Rat: 100%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against ACSL6. It was validated on Western Blot.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human ACSL6
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- ACSL6 (Acyl-CoA Synthetase Long-Chain Family Member 6 (ACSL6))
-
Andere Bezeichnung
- ACSL6
-
Hintergrund
-
The protein encoded by this gene catalyzes the formation of acyl-CoA from fatty acids, ATP, and CoA, using magnesium as a cofactor. The encoded protein plays a major role in fatty acid metabolism in the brain. Translocations with the ETV6 gene are causes of myelodysplastic syndrome with basophilia, acute myelogenous leukemia with eosinophilia, and acute eosinophilic leukemia. Several transcript variants encoding different isoforms have been found for this gene.
Alias Symbols: ACS2, FACL6, LACS2, LACS5, LACS 6
Protein Size: 558 -
Molekulargewicht
- 61 kDa
-
Gen-ID
- 23305
-
NCBI Accession
- NM_001009185, NP_001009185
-
UniProt
- Q9UKU0
Target
-